Connect with Arizonans at RESI and BIO2023 in Boston

Arizona Health Innovators are headed to Boston for RESI and the BIO International Convention June 5 - 8. 2023.


Steve Potts, PhD,  President & CEO, Anticipate Bioscience


Joan Koerber-Walker,  President & CEO, AZBio

  • RESI - Monday, June 5th, 2:00 - 2:50 PM, CNS Diseases panel: Advancing Novel Drugs & Preventative Therapies in CNS Disorders

Dylan N. Peay, Entrepreneurship & Talent, AZBio

Allison Grigg

Jami Mei, Project Manager, Business Attraction team, Arizona Commerce Authority

Cameron Robb,  Senior Economic Development Consultant, Arizona Public Service (APS).


Kelly Sandin, Assistant Director, Economic Development and Innovation Zones, Arizona State University’s Knowledge Enterprise

Rob Hahn-Lowry, Corporate Vice President and Chief of Staff for the Office of the President, Caris Life Sciences

John Cheneval, Executive Director, Business Development, Castle Biosciences

Christine Mackay, Director, Community & Economic Development, City of Phoenix

Nathan Wright, Deputy Director – Business Attraction Division, City of Phoenix Community & Economic Development, City of Phoenix

Xandon Keating. Deputy Director – Community Development Division, City of Phoenix Community & Economic Development, City of Phoenix

Martin Perez, Special Projects Administrator, City of Phoenix Community & Economic Development, City of Phoenix

Claudia Whitehead, Bioscience Healthcare Program Manager, Community & Economic Development, City of Phoenix

Gabrielle Finley-Hazle, President and Chief Executive, Officer,  Arizona Central and West Valley, Dignity Health

Shwetal Mehta, PhD, Chief Operating Officer and Deputy Director, Ivy Brain Tumor Center at Barrow Neurological Institute

Jocelyn Harmon, MS, Director of Clinical Operations, Ivy Brain Tumor Center

Melinda Langdon, Director of Marketing and Communications, Ivy Brain Tumor Center


Evan Darzi, PhD,  CEO, Co-Founder, ElectraTect

Christina Forbes, PhD, Senior Scientist, ElectraTect

Jennifer Thompson, Chief Executive Officer and Co-founder, Faknostics

Timothy Marlowe, PhD, Chief Scientific Officer, Faknostics

Ronald Nelson PhD, Senior Laboratory & Operations Manager, Faknostics

Mark Paratore, Vice President, Business Development, GPEC

Casey Gilchrist, Senior Director, International Business Development, GPEC


Daniela Iwanski , Vice President, BioPharma Recruiting, Govig


George Colberg, Executive Chairman & CEO, Co-founder & Director, Kalos Therapeutics & Ocellis


David Schwartz, Director, Strategy, Mayo Clinic, Arizona

William A. Faubion, M.D. Professor of Immunology, Medicine and Pediatrics, Dean for Research, Mayo Clinic, Arizona

Mark Engstrom, Director, Office of Real Estate, Mayo Clinic

Aric H. Bopp, CEcD, Executive Director, Discovery Oasis at Mayo Clinic, Arizona

Steven Lester, MD, Founder and Chief Medical Officer, Mayo Clinic-Arizona State University MedTech Accelerator

Evan UngerPresident & CEO

Emmanuelle Meuillet, PhD, Chief Scientific and Operating Officer, Microvascular Therapeutics

Evan UngerPresident & CEO, NuvOx Pharma
Rong WangChief Operating and Financial Officer, NuvOx Pharma

Robert Bowser, PhD., Chairman of the Board, nVector

Scarlett Spring, Executive Director of the Phoenix Bioscience Core

Kiran Avancha, PhD, CEO & CoFounder, Prizm Therapeutics


Inga Rose, Founder and CEO, Reference Medicine


Richard Austin, Co-founder and CEO, Reglagene

Brad Morie, Sr. Director, Biotechnologies, Research Corporation Technologies

Marc Valenzuela, Senior Economic Development Project Manager, Salt River Project

Alastair Malcolm, CEO, Applied Microarrays (a SCHOTT Company)

James Downs, Global Business Development, Schott Minifab 

Laura Eggink, Founder/Scientist, Susavion Biosciences, Inc.

Arthur Tinkelenberg, Strategic Advisor

Caron Davis, Vice President of Business Development, City of Hope Phoenix & Vice President of Business Development, Strategic initiatives, TGen (Translational Genomics Research Institute)

Jacob Busch, MBA, Research Operations Manager & Institutional Initiatives Coordinator, TGen (Translational Genomics Research Institute)

Kaitlyn Morse, PhD, co-founder & CEO, VaxSyna

Posted in AZBio News.